Researchers at Scripps Research developed a microchip capable of rapidly mapping how human antibodies bind to viruses from a single drop of blood. This novel technology provides faster, clearer insights into antibody-virus interactions, expediting vaccine development and antibody discovery. The approach offers greater resolution in understanding immune responses, facilitating the design of more effective vaccines and therapeutics by revealing previously hidden viral epitopes.